Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community

[1] Coque TM(2008)Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15 Emerg Infect Dis 14 195-200

[2] Novais A(2006)Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups Antimicrob Agents Chemother 50 2741-2750

[3] Carattoli A(2004)Growing group of extended-spectrum b-lactamases: the CTX-M enzymes Antimicrob Agents Chemother 48 1-14

[4] Poirel L(2006)The CTX-M β-lactamase pandemic Curr Opin Microbiol 9 466-475

[5] Pitout J(2005)Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community J Antimicrob Chemother 56 52-59

[6] Peixe L(2013)Community-acquired CTX-M-15-type ESBL-producing J Infect Dev Ctries 13 424-431

[7] Baquero F(2003) meningitis: a case report and literature review Antimicrob Agents Chemother 47 2382-2383

[8] Cantón R(2013)Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five U.S. states Clin Microbiol Rev 26 744-758

[9] Nordmann P(2012)Trends in human fecal carriage of extended- spectrum β-lactamases in the community:toward the globalization of CTX-M J Antimicrob Chemother 67 1769-1774

[10] Novais A(2012)Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities BMC Infect Dis 12 1-5

[1] Coque TM(2008)Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15 Emerg Infect Dis 14 195-200

[2] Novais A(2006)Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups Antimicrob Agents Chemother 50 2741-2750

[3] Carattoli A(2004)Growing group of extended-spectrum b-lactamases: the CTX-M enzymes Antimicrob Agents Chemother 48 1-14

[4] Poirel L(2006)The CTX-M β-lactamase pandemic Curr Opin Microbiol 9 466-475

[5] Pitout J(2005)Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community J Antimicrob Chemother 56 52-59

[6] Peixe L(2013)Community-acquired CTX-M-15-type ESBL-producing J Infect Dev Ctries 13 424-431

[7] Baquero F(2003) meningitis: a case report and literature review Antimicrob Agents Chemother 47 2382-2383

[8] Cantón R(2013)Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five U.S. states Clin Microbiol Rev 26 744-758

[9] Nordmann P(2012)Trends in human fecal carriage of extended- spectrum β-lactamases in the community:toward the globalization of CTX-M J Antimicrob Chemother 67 1769-1774

[10] Novais A(2012)Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities BMC Infect Dis 12 1-5